Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration ...

Vision changes are an inevitable part of aging, but why are some more susceptible to age-related eye diseases and why do some ...

COAST Phase 3 trial evaluates superiority and safety of sozinibercept combined with aflibercept in wet AMDCompany confirms topline results for ...

FORT LAUDERDALE, FL / ACCESS Newswire / February 18, 2025 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") , a clinical-stage biopharmaceutical company focused on the research and development of ...

Dr. Lucas Brown, DAOM, LAc, spoke with Studio 512 about how his clinic, Rosedale Acupuncture & Wellness, can help with ...

Hardware cybersecurity pioneer X-PHY Inc (the "Company") today announced the appointment of Wayne Maw as its US General Manager. With extensive experience in technology leadership, business ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of ...

A neurologist recently shared on social media three things he would never do to protect his brain and health. Mayo ...

In the last few days something shameful has made headlines in the print and electronic media. It has become a norm these days ...

Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® (CT-P42, aflibercept), a biosimilar to Eylea® to ...